CL
Clover Health
CLOV · NASDAQ
$4.82 +1.47% (+$0.07)
1M +4.78%
Market Cap $2.44B
P/E Ratio -
Div. Yield -
ROE 5.38%
Bulios Fair Price
$3.94
18.3% downside
Current Price
$4.82
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CLOV is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
48 /100
Fair P/S 0.99x
P/B 6.49x
P/FCF 32.89x
Growth
78 /100
Growing Rev. growth 20.62%
Book val. growth 4.72%
EPS growth N/A
Profitability
13 /100
Weak Gross margin 18.57%
Net margin 0.74%
FCF margin 3.00%
Quality
15 /100
Poor ROIC 4.62%
ROE 5.38%
Asset turnover 3.44x
Debt
92 /100
Low Debt/Equity 0.00x
Current ratio 1.50x
Int. coverage N/A
Stability
21 /100
Unstable Beta 2.48x
Rev. volatility 16.73%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CLOV
Online
Sector
Healthcare
Industry
Medical - Healthcare Plans
CEO
Andrew Toy
Employees
724
Headquarters
Wilmington
Upcoming events
04 NOV
Earnings
Upcoming earnings report